Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CNA
CNA logo

CNA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy CNA Financial Corp (CNA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
46.240
1 Day change
1.14%
52 Week Range
51.180
Analysis Updated At
2026/04/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

CNA Financial Corp is not a strong buy for a beginner, long-term investor at this time. While the company has shown impressive financial growth in the latest quarter, the technical indicators, options data, and analyst sentiment suggest limited upside potential in the near term. Additionally, hedge fund selling and lack of positive catalysts further support a cautious approach.

Technical Analysis

The MACD is positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 57.903, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 46.272), suggesting limited immediate upside. Historical trends indicate potential short-term declines (-0.75% next day, -1.49% next week, -4.27% next month).

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
5

Positive Catalysts

  • The company's Q4 financials show strong YoY growth in revenue (3.77%), net income (1338.10%), and EPS (1287.50%), which could support long-term investor confidence.

Neutral/Negative Catalysts

  • Hedge funds are aggressively selling (46459.29% increase in selling activity last quarter). Analysts have an 'Underperform' rating, citing rising loss costs and flat personal auto rates. No recent news or congress trading data to indicate positive sentiment or events.

Financial Performance

In Q4 2025, CNA Financial reported revenue of $3.828 billion (up 3.77% YoY), net income of $302 million (up 1338.10% YoY), and EPS of $1.11 (up 1287.50% YoY). These figures indicate strong financial growth but may not offset broader market concerns.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

BofA raised the price target to $47 from $45 but maintained an 'Underperform' rating. Analysts highlight rising loss costs and flat personal auto rates as concerns, despite positive liability line pricing.

Wall Street analysts forecast CNA stock price to rise
1 Analyst Rating
Wall Street analysts forecast CNA stock price to rise
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 45.720
sliders
Low
47
Averages
47
High
47
Current: 45.720
sliders
Low
47
Averages
47
High
47
BofA
Underperform
maintain
$45 -> $47
AI Analysis
2026-01-05
Reason
BofA
Price Target
$45 -> $47
AI Analysis
2026-01-05
maintain
Underperform
Reason
BofA raised the firm's price target on CNA Financial to $47 from $45 and keeps an Underperform rating on the shares. As in 2025, the pricing trends for most P&C insurance products do not appear positive, the analyst tells investors in a research note. While pricing for liability lines remains positive, it seems that loss costs are rising more steeply than prices, the analyst says, adding that personal auto rates are flattish, while some investors are expecting decline in response to high profitability. The firm added, however, that underwriter valuations hardly look expensive, even as fundamentals have tipped in the "wrong direction."
JPMorgan
Pavan Mahbubani
Neutral -> Overweight
upgrade
203 GBp
2025-12-11
Reason
JPMorgan
Pavan Mahbubani
Price Target
203 GBp
2025-12-11
upgrade
Neutral -> Overweight
Reason
JPMorgan analyst Pavan Mahbubani upgraded Centrica to Overweight from Neutral with a 203 GBp price target. The company's discipline on capital allocation underpins the firm's positive stance, and JPMorgan contends that 2026 will begin a period of transformation efficiency, with expectations of an announcement alongside FY25 results driving its above-consensus medium term estimates, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNA
Unlock Now

People Also Watch